Advanced search
Start date
Betweenand

In vitro evaluation of cellular migration and invasion in breast cancer in response to treatment with metiformin and Y27632 after induction process of epithelial mesenchymal transition.

Grant number: 12/15592-8
Support type:Scholarships in Brazil - Scientific Initiation
Effective date (Start): December 01, 2012
Effective date (End): November 30, 2013
Field of knowledge:Agronomical Sciences - Veterinary Medicine
Principal researcher:Debora Aparecida Pires de Campos Zuccari
Grantee:Michel Raineri Haddad
Home Institution: Faculdade de Medicina de São José do Rio Preto (FAMERP). Secretaria de Desenvolvimento Econômico (São Paulo - Estado). São José do Rio Preto , SP, Brazil

Abstract

The breast cancer is the worldwide most commom neoplasia in women, and its malignancy centered on its highly invasive and metastatic actions. The expression of ROCK-1 is associated with malignant, whereas inhibition of this signaling molecule results in a significant suppression of tumor metastasis. Likewise, the transforming growth factor beta (TGF-²) has been linked to its power to induce epithelial-mesenchymal transition (EMT), which provides greater mobility and an invasive phenotype of these tumor cells. However, new therapeutic options have been used to inhibit these processes, in which metformin, a drug used to treat type 2 diabetes, has shown good results in research on breast cancer, reducing its incidence and prognosis favoring, through mechanisms not completely understood, but involving, among many other markers, TGF-². From the effect of TGF-² and protein expression of ROCK-1 in promoting cancer malignancy, we intend to evaluate the effects of metformin with or without the ROCK inhibitor-1, Y27632, and alternative therapies for inhibition of metastasis breast cancer in vitro.

News published in Agência FAPESP Newsletter about the scholarship:
Articles published in other media outlets (0 total):
More itemsLess items
VEICULO: TITULO (DATA)
VEICULO: TITULO (DATA)